Keefe Bruyette raised the firm’s price target on Globe Life (GL) to $137 from $135 and keeps an Outperform rating on the shares as part of a Q4 life insurance preview. The firm lowered Q4 earnings estimates by 5% on average citing softer variable investment income, lower market returns, and unfavorable currency moves. It expects much of the focus this quarter to be on 2025 outlooks.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GL:
- Globe Life upgraded to Outperform from In Line at Evercore ISI
- Globe Life price target raised to $114 from $107 at Jefferies
- JPMorgan sees ‘several inaccurate’ claims in Globe Life short report
- Viceroy Research says ‘something seriously wrong’ at Globe Life’s AIL
- Globe Life refutes ‘false’ short seller report